Urine patches from grazing cattle are hotspots of nitrous oxide (NO) emissions. The default IPCC emission factor for urine patches (EF) is 0.77% for wet climates and 0.32% for dry climates. However, literature reports a considerable range of cattle urine EF values and urine characteristics used in experimental studies, revealing contrary results on the effects of urine patch characteristics and seasonal pattern. Therefore, we examined NO emissions and corresponding EF values in relation to urine patch characteristics (urine N concentration, urine volume, patch area, urine composition) and environmental drivers (precipitation, water filled pore space, soil temperature). Ten artificial urine application experiments were performed from July 2020 to June 2022 on a pasture located in Eastern Switzerland. Urine N concentration, patch area, volume and urine N composition showed no significant effects on the EF value (p > 0.05). EF varied, however, strongly over time (0.17-2.05%). A large part of the variation could be predicted either by cumulative precipitation 20 days after urine application using a second order polynomial model (Adj. R = 0.60) or average WFPS 30 days after urine application using a linear model (Adj. R = 0.45). The derived precipitation model was used to simulate EF weekly over the last 20 years showing no significant differences between the seasons of a year. The resulting overall average EF was 0.67%. More field studies are needed across sites/regions differing in climate and soil properties to implement a country-specific EF for Switzerland and to improve the quantification of NO emissions at the national scales.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576711 | PMC |
http://dx.doi.org/10.1007/s10705-023-10290-0 | DOI Listing |
Trials
January 2025
Department of Traditional Chinese Medicine, The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen, 518033, Guangdong, P. R. China.
Background: The aim of this study is to evaluate the efficacy and safety of diacylglycerol (DAG) edible oil intervention in patients with chronic metabolic syndrome complicated by asymptomatic hyperuricemia through a multicenter, prospective, double-blind, randomized controlled clinical trial.
Methods: A multicenter, double-blind, and randomized controlled trial involving 176 patients was designed. All patients with chronic metabolic syndrome complicated by asymptomatic hyperuricemia who meet inclusion and exclusion criteria will be included in the study and will be randomized to either group A or group B.
J Med Case Rep
January 2025
Department of Urology, SRM Institute of Science and Technology, SRM Nagar, Chengalpattu, Kattankulathur, Tamilnadu, 603203, India.
Background: The diagnosis and management of female genital conditions (Rodriguez et al. in Clin Anat 34(1):103-107, 2020. https://doi.
View Article and Find Full Text PDFJ Fluoresc
January 2025
Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, Phayathai Road Pathumwan, 10330, Thailand.
This study presents a new highly sensitive and specific time-resolved fluoroimmunoassay (TRFIA) for the measurement of trace amounts of the urinary 8-hydroxy-2`-deoxyguanosine (8-OHdG) which is a biomarker for oxidative stress on DNA. The assay relied on a competitive binding approach and a mouse monoclonal antibody which recognized 8-OHdG with high specificity. In this assay, 8-OHdG conjugated with bovine serum albumin protein (8-OHdG-BSA) was employed as a solid phase antigen.
View Article and Find Full Text PDFEur J Pediatr
January 2025
Pediatric Nephrology AB, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
Purpose: Study aimed to compare incidence of urinary tract infection (UTI), type of bacteria grown, development of antibiotic resistance over 2 years in children whose caregivers underwent training based on the Roy Adaptation Model with an android phone application for patients clean intermittent catheterization (RAMACIC) versus those whose caregivers received routine training in hospital.
Method: This study was conducted as a descriptive, prospective study with 40 patients and caregivers between October 2021 and 2023 as a continuation of a previously conducted randomized controlled experimental study by the researchers. Data were collected the "Participant Form," and "Urine Test Form" analyzed with the SPSS 22 package.
Sci Rep
January 2025
Department of Chromosome Biomedical Engineering, School of Life Science, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683‑8503, Japan.
Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder caused by mutations of the dystrophin gene, which spans 2.4 Mb on the X chromosome. Creatine kinase (CK) activity in blood and titin fragment levels in urine have been identified as biomarkers in DMD to monitor disease progression and evaluate therapeutic intervention.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!